Top Biopharmaceutical Experts 2025

Dr. Sarassawadee Suwanjinda ("Dr. Petch") is Co-Founder and Chief Medical Strategy Officer at Healthi Life, Bangkok's Urban Longevity House. Certifications: - International Board of Lifestyle Medicine (IBLM) - International Society for Stem Cell Application (ISSCA) - Certified Board of Anti-Aging Medicine (CBAM) - American Academy of Aesthetic Medicine (AAAM) - Certificate in Aesthetic Medicine 10+ years of clinical experience in longevity, regenerative, functional, and lifestyle medicine. Available for expert medical commentary on: - Longevity medicine and healthspan extension - Stem cell and exosome therapy safety - NAD+ IV therapy and mitochondrial health - Peptide therapy and physician oversight (Tirzepatide, Retatrutide, BPC-157) - Hormone optimization (testosterone, perimenopause) - 300+ biomarker health check-ups - Functional medicine for chronic conditions Located in Ekkamai, Bangkok. Serving 50+ nationalities.

Vardan Ter-Antonyan is a pharmaceutical research and development executive with more than 20 years of experience advancing products from concept through commercialization. His expertise spans drug formulation, pharmaceutical development, manufacturing scale-up, quality systems, regulatory strategy, and commercialization across pharmaceuticals, medical devices, nutraceuticals, cannabinoids, and medical technologies. Throughout his career, Vardan has led multidisciplinary R&D teams, developed novel drug delivery systems, optimized manufacturing processes, and helped organizations bring innovative products to market while navigating complex regulatory requirements. His technical expertise includes lipid-based drug delivery systems, nanoemulsions, self-emulsifying drug delivery systems (SEDDS/SNEDDS), liposomes, controlled-release technologies, and formulation development for poorly water-soluble compounds. In addition to his scientific leadership, Vardan is passionate about bridging the gap between research and commercial success. He regularly advises companies on product development strategy, technology commercialization, operational excellence, and innovation management. His work combines deep scientific knowledge with practical business insight, enabling organizations to accelerate development timelines, improve product quality, and reduce technical risk. Vardan is also an author, speaker, and industry thought leader who enjoys sharing evidence-based perspectives on pharmaceutical innovation, drug delivery, biotechnology, diagnostics, manufacturing, and executive leadership. He welcomes opportunities to provide expert commentary for journalists covering advances in pharmaceutical science, healthcare innovation, biotechnology, regulatory affairs, and emerging medical technologies.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Vincent Caradec is the French CEO and Co-Founder of Healthi Life (healthi-life.com), Bangkok's Urban Longevity House — a physician-led longevity, preventive and regenerative medicine clinic serving 50+ nationalities. Available for expert commentary on: - Building a longevity clinic in Asia - Medical tourism market trends in Thailand and Southeast Asia - CEO insights on preventive medicine adoption - GLP-1 weight management market (Tirzepatide, Retatrutide, Mounjaro, Wegovy) - Stem cell, exosome and NAD+ regenerative therapies - 300+ biomarker testing programs and longevity diagnostics - Wellness industry business strategy and pricing - Asian healthcare entrepreneurship Healthi Life operates an integrated longevity center offering check-ups, 3-12 month longevity programs, corporate wellness contracts and advanced regenerative therapies (stem cells, exosomes, NAD+, peptides, IV therapy). French national based in Bangkok. Fluent in English and French. Available for interviews on Zoom, Google Meet, WhatsApp.

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Dr. Fouad Ghaly is a physician, regenerative medicine expert, and founder of the Ghaly Center for Regenerative Medicine in Torrance, California. Since 1995, Dr. Ghaly has focused on helping men and women optimize health, vitality, and longevity through an integrative approach that combines conventional medicine, regenerative therapies, preventative health strategies, and emerging scientific research. His areas of expertise include healthy aging, cellular health, hormone optimization, platelet-rich plasma therapy, stem cell-related regenerative approaches, energy and performance optimization, and individualized wellness planning. Dr. Ghaly is also the creator of Gevity24, a longevity-focused supplement formula designed to support wellness, vitality, and healthy aging. As a physician-educator, Dr. Ghaly is passionate about translating complex medical and longevity science into practical, understandable insights for patients, journalists, and the public. He is available to comment on regenerative medicine, longevity, preventative health, men’s and women’s wellness, cellular optimization, supplementation, and the future of personalized medicine.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Hello, I'm Gabrielle M., Founder and CEO of DERMA-CODE™ LLC. I co-authored Skincare Through Biology Made Simple with Dr. Mohan Muvvala, DO, MBA a peer-reviewed educational resource designed to close the gap between what consumers are told and what the science actually says. DERMA-CODE™ has been featured in Skin Inc. magazine, and I've been actively contributing pieces to Skin Inc. over the past several months. DERMA-CODE™ is a biotech skincare brand launched in November 2025 built around one principle: skincare should be grounded in biology, not marketing. The brand develops fully proprietary formulations with disclosed active percentages, no white labeling, and no paid placements. Our two hero products the PDRN + NAD+ Pulse Serum and Locked-In Moisturizer are currently undergoing an active REB-approved third-party clinical study using instrumented skin measurement and blinded dermatologist grading. I speak on ingredient science, formulation integrity, clinical evaluation, and the disconnect between industry claims and published research. When you quote me, you’re not getting a brand rep reading from a script. You’re getting a founder who has spent years inside the science working alongside a team of researchers to understand exactly how ingredients behave, how formulations are built, and where the industry falls short. Every answer I give is grounded in published research and real formulation experience. I don’t guess, I don’t generalize, and I don’t send talking points. If I’m the right source for your story, you’ll know it from my first response.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

I am an entrepreneur and business leader with extensive experience building, scaling, and exiting nationally recognized dietary supplement and weight management brands. My background spans supplement manufacturing, product development, formulation strategy, operations, supply chain, direct-to-consumer marketing, and brand growth within the wellness industry. I have founded and grown multiple consumer health brands from concept through commercialization and acquisition, including Pounds Off, Lipozene, Inmit Fasting, and Fiber Thin. Throughout my career, I have led product innovation, manufacturing partnerships, regulatory compliance, quality assurance, customer acquisition, e-commerce growth, retail expansion, and large-scale direct response marketing campaigns. My expertise lies in turning product ideas into scalable businesses by aligning formulation, manufacturing, marketing, operations, and financial strategy. I have built high-performing teams, negotiated strategic partnerships, launched new product lines, optimized retention strategies, and led successful merger, acquisition, and exit transactions. I bring a practical, growth-focused perspective to supplement brand development, helping companies identify opportunities, improve operational efficiency, strengthen product-market fit, and increase long-term enterprise value.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Dr. Bruce Dorr is boarded in Obstetrics and Gynecology and subspecialty boarded in Urogynecology and Reconstructive Pelvic Surgery as well as fully certified with the Institute for Functional Medicine. He also serves as senior medical advisor for Biote. For the last two decades he has directed his practice towards a functional medicine practice of hormone health and wellness and became IFM certified in 2025. Dr. Dorr joined Littleton GYN & Wellness in 1997. He enjoys using his teaching skills in the private practice setting to educate his patients about various aspects of their health. He is a member of the American Urogynecology Society, the Menopause Society and the Sexual Medicine Society of North America. As a Platinum Educator and Key Opinion Leader, he’s delivered over 70 national physician training programs and led physician training for major clinical trials, including Mirena Phase III, the Yaz PMDD and acne studies, and the IoGen molecular iodine trial. Dr. Dorr has held several leadership roles at Littleton Adventist Hospital, including Chairman of the OB/GYN Department and founder/co-chair of the Robotics Committee. He served as a Da Vinci Surgical Proctor and Educator and currently holds a role as an InMode Key Opinion Leader and Faculty Speaker. He has also been honored to hold an appointment as Assistant Professor of Obstetrics and Gynecology at Denver Health Medical Center/University of Colorado School of Medicine. He has worked as a locum tenens physician across underserved areas throughout the country and with the Indian Health Service in Chinle, Arizona, and led surgical Mission trips with Centura Global Health Initiatives in Nepal and Peru. Dr. Dorr held several positions at AdventHealth Hospital including Chairman of the OB/GYN Department, Director of Pelvic Floor Services, Chairman of the Peer Review Committee and member of the Credentialing Committee. He was also a reviewer for the Colorado Medical Board.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

After more than a decade inside one of the world’s largest biopharmaceutical companies, I’ve started a new chapter, one I’ve been quietly building toward for years. I’m the founder of RWD Insights, where I advise life sciences companies, health tech startups, and AI/ML organizations on turning complex data into real clinical and commercial value. I work with a small number of clients at a time, as a strategic advisor and executive sounding board, not a full-service firm. My career has lived at the intersections: between data scientists and the C-suite, between technical rigor and business strategy, and always between what the science can do and what actually improves outcomes for patients. As a Global Head of Digital Transformation and, before that, Data Governance and Insights, I learned how pharma really evaluates, buys, and implements data and AI, and how to keep patient-centricity and evidence-based decisions at the center of that work. That buyer’s-seat perspective is what I bring to every engagement now. I’m a PhD biostatistician (University of Pennsylvania, School of Medicine) who teaches in Columbia’s Applied Analytics Program and mentors founders on AI and Data strategy at NYU Stern’s Endless Frontier Labs. My published work spans pragmatic trials, real-world evidence, and HEOR, and I’ve been recognized by DataIQ as a top global data and AI leader. What I care about most is the same thing that’s driven my whole career: connecting business needs, the right data, and the right methods so the work delivers real evidence and better outcomes for patients.

Tomo Marjanovic is the Founder and CEO of Aspire Rejuvenation Clinic, a multi-million dollar hormone optimization and regenerative medicine company with clinics in four U.S. cities and expansion underway in Cleveland and Dubai. Named a Top 100 Healthcare Visionary by IFAH, Marjanovic has treated thousands of patients through bioidentical HRT, peptide therapy, stem cell and exosome treatments, and medical weight loss programs. Before building Aspire, Marjanovic spent 12 years in law enforcement in Ohio and Florida, earning the Public Safety Medal of Valor. After chronic night shift work destroyed his hormonal health and the medical system failed to help, he got certified in Advanced Bioidentical Hormone Replacement Therapy through Worldlink Medical and built the company he wished existed when he was the patient. Marjanovic is the author of "Operation Optimal: Health, Wellness, & Becoming Your Best You" and host of the Tomo Talks podcast. He holds a BA in Criminal Justice Administration (Cum Laude) from Tiffin University and is a former competitive bodybuilder. His work has been featured in USA Today, NY Post, Miami Herald, Modern Luxury, and Authority Magazine. He is available to speak on hormone optimization, testosterone therapy, longevity medicine, regenerative therapies, peptides, men's health, stress and cortisol, health entrepreneurship, veteran and first responder wellness, the GLP-1 market, healthcare franchising, and the intersection of health and wealth.

I edit Europe Pharma Today — a Europe-first news desk covering EMA and CHMP decisions, EU HTA, and national market-access moves for industry professionals. We focus on what changed, what it means for access, and what to watch next — with clear sourcing, not noise.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

I am the Chief Medical Officer at Boomerang Health Care, a state of the art multidisciplinary specialty group offering interventional, surgical and rehabilitative care through its 25 clinics in California. I also serve as the Medical Director at Le Reve: Regen, a leader in cutting edge restorative and regenerative solutions for Spine, Orthopedics and Musculoskeletal conditions. In the academic world, I have served as a Clinical Faculty at Stanford University for more than 20 years and have established myself as a world leader in cutting edge innovative therapeutic solutions. I completed her Anesthesiology residency from Medical College of Wisconsin, Milwaukee and Fellowship in Pain Medicine from the University of California, Davis. I am board certified in Anesthesiology and Pain Medicine by American Board of Anesthesiology, in Interventional Pain by American Board of Interventional Pain Physicians and in Regenerative Medicine by American Board of Regenerative Medicine. I sit on the Editorial board of the journal, Pain Physician and serve on the board of the American Society of Interventional Pain Physicians, Latin American Pain Society, California Society of Industrial Medicine and Surgery, California Society of Interventional Pain Physicians and Scilex (Nasdaq: SCLX). I am humbled to receive the Distinguished Service Award, Outstanding Achievement Awards and other accolades. I have devoted my entire career to the field of Interventional spine and Regenerative medicine and have contributed via several peer reviewed journal articles, visionary editorials, and book chapters. My book, “Essentials of Regenerative Medicine” is first in its right illustrating latest interventional biologic techniques for spine and musculoskeletal injuries. I have also authored several National Guidelines including the ones on Opioids, Interventional Spine Epidural procedures, Facet joints, and the first ever on the Safe and Effective use of Biologics in Lumbar spine. I have completed the first prospective, multicenter, randomized placebo controlled trial demonstrating efficacy of platelet rich plasma and bone marrow concentrate in patients with back pain related to disc injury/degeneration. I consider myself an authority on global health care trends including digital health, technology innovations and applied biologics. Let’s connect and work together to make healthcare better, faster, and more effective – www.annunavani.com.